Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
| Revenues | 0.5 | 0.7 | 0.0 | 19.0 | |
| Revenue growth | -34.6% | 2310.0% | -99.8% | | |
| Cost of goods sold | 0.0 | 0.3 | 0.0 | 0.0 | |
| Gross profit | 0.4 | 0.4 | 0.0 | 19.0 | |
| Gross margin | 94.5% | 60.0% | 100.0% | 100.0% | |
| Selling, general and administrative | | | 20.4 | 9.5 | |
| Research and development | 31.9 | 28.4 | | 9.6 | |
| General and administrative | 16.9 | 22.0 | | 6.8 | |
| EBIT | -48.4 | -50.0 | -1.6 | -16.3 | |
| EBIT margin | -10234.5% | -6912.6% | -5233.3% | -85.8% | |
| Pre-tax income | -29.9 | -10.2 | -18.9 | -16.2 | |
| Income taxes | 0.0 | -0.4 | 0.4 | 0.0 | |
| Tax rate | 0.0% | 4.2% | | 0.0% | |
| Net income | -29.9 | -9.7 | -19.3 | -16.2 | |
| Net margin | -6325.2% | -1347.2% | -64256.7% | -84.9% | |
| |
| Diluted EPS | ($0.46) | ($0.16) | ($1.10) | ($0.93) | |
| Shares outstanding (diluted) | 65.2 | 61.6 | 17.5 | 17.4 | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|